RE: Coming home to roost14 Jul 2024 09:16
Hi Dan,I like you have not sold over the years.I first invested on the drop from £8,clevergen was then just a twinkle in the eye of Markku,with the company still concentrating on Traumakine.Dont forget Bex showed great promise in the treatment of solid tumours aswell,as soon as we get it over the line for MDS,the company can then move on to treating many other cancers with BEX.The last six months has been a bit stressful for us LTH to say the least,but I really believe our faith in Faron is going to be rewarded soon.GLA